About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Stage IV NSCLC ALK+ 74 y/o Male With Brain Metastases: Outcomes of Genomic Profiling - FISH Testing vs. NGS
By
Stephen Liu
9 Videos
FEATURING
Julie Brahmer
,
Benjamin Levy
700 views
April 1, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
26:21
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…
Feat.
M. Hwang
20:52
Total Health
Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…
Feat.
T. Boyle
11:12
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…
Feat.
A. Herrera
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
20:27
Yale Cancer Center
Progress in the Treatment of NSCLC
Feat.
R. Herbst
15:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…
Feat.
A. Evens
08:15
ecancer
ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"
Feat.
B. Gyawali
07:38
GRACE
How Does PD-L1 Score Affect Treatment Options for NSCLC
Feat.
S. Patel,
T. Leal,
P. Iyengar,
A. Desai,
C. Kim,
J. Rotow
04:31
Integrity Continuing Education
Neoadjuvant and Adjuvant Treatment in Early Stage NSCLC: Options Are…
Feat.
J. Gainor,
J. Sands
20:28
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
Feat.
C. Aggarwal
10:04
Stephen M. Ansell
NCCN Guidelines for the Treatment of cHL: A New Standard of Care
10:34
GRACE
ASCO® 2023 Insights: "CheckMate 9LA 4-Year Follow-Up - Chemo + …
Feat.
J. West,
C. Lovly,
A. Addeo
07:13
Insights from 2023 WCLC
WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSC…
Feat.
S. Gadgeel
13:01
Nebraska Oncology Society
ASCO 2022 on Immunotherapy Updates in Advanced NSCLC
Feat.
J. Brahmer
23:17
OncoAlert
Early NSCLC Updates: EGFRm, ALK+ Disease & Neoadjuvant IO
Feat.
G. Lopes
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
2024 Neuro-Oncology Update: NSCLC and Brain Mets
Feat.
T. McGranahan
17:44
Total Health
Novel Approaches in the Treatment of NSCLC
Feat.
E. Massarelli
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
